Key facts
- This page summarizes Robert Keith Warner's Form 4 filing for RxSight, Inc. (RXST).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Jun 2023, 16:37.
Robert Keith Warner - 01 Jun 2023 Form 4 Insider Report for RxSight, Inc. (RXST)
- Reporting relationship
- Director
- Issuer ticker
- RXST
- Reported as of
- 01 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Jun 2023, 16:37:16 UTC
- Prior SEC filing
- 19 May 2023
- Next SEC filing
- 12 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shelley Thunen, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Keith Warner filed Form 4 for RxSight, Inc. (RXST) on 05 Jun 2023.
Change
- Previous filing in this sequence was filed on 19 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RXST
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,731
- Change %
- +26%
- Price
- $0.000000
- Shares after
- 27,733
- Date
- 01 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F2
RXST
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 43,750
- Date
- 01 Jun 2023
- Ownership
- See footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
Footnote F2
Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 1, 2023.
Footnote F3
Shares held by the Cabo Living Trust, for which the Reporting Person serves as trustee.